Drug Shortage Report for MYLAN-VALACYCLOVIR
Report ID | 207184 |
Drug Identification Number | 02351560 |
Brand name | MYLAN-VALACYCLOVIR |
Common or Proper name | VALACYCLOVIR |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | VALACYCLOVIR |
Strength(s) | 1000MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | J05AB |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-11-15 |
Actual start date | 2023-10-27 |
Estimated end date | Unknown |
Actual end date | 2023-11-15 |
Shortage status | Resolved |
Updated date | 2024-05-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-05-15 | French | Compare |
v7 | 2024-05-15 | English | Compare |
v6 | 2023-11-14 | French | Compare |
v5 | 2023-11-14 | English | Compare |
v4 | 2023-10-30 | French | Compare |
v3 | 2023-10-30 | English | Compare |
v2 | 2023-10-17 | French | Compare |
v1 | 2023-10-17 | English | Compare |
Showing 1 to 8 of 8